Thomas Cerny

2.8k total citations
53 papers, 2.2k citations indexed

About

Thomas Cerny is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Thomas Cerny has authored 53 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 16 papers in Molecular Biology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Thomas Cerny's work include Lung Cancer Treatments and Mutations (6 papers), Palliative Care and End-of-Life Issues (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Thomas Cerny is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Palliative Care and End-of-Life Issues (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Thomas Cerny collaborates with scholars based in Switzerland, Germany and United Kingdom. Thomas Cerny's co-authors include N. Thatcher, Florian Strasser, P S Hasleton, Jim Heighway, Ulrich Güller, Markus Joerger, René Warschkow, Thomas Ruhstaller, Bruno M. Schmied and Mathias Worni and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgery and British Journal of Cancer.

In The Last Decade

Thomas Cerny

53 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Cerny Switzerland	25	921	568	477	307	248	53	2.2k
John W. Loewy United States	21	703 0.8×	374 0.7×	386 0.8×	281 0.9×	236 1.0×	39	2.3k
Nicola Cooper United Kingdom	22	719 0.8×	742 1.3×	380 0.8×	119 0.4×	135 0.5×	97	2.3k
Anne Tang United States	24	1.2k 1.3×	1.0k 1.8×	451 0.9×	153 0.5×	171 0.7×	54	3.1k
D. Lynne Smith United States	25	799 0.9×	1.0k 1.8×	228 0.5×	270 0.9×	292 1.2×	76	2.4k
Joseph A. Lucci United States	27	968 1.1×	348 0.6×	381 0.8×	196 0.6×	336 1.4×	89	2.7k
Masaru Narabayashi Japan	28	1.0k 1.1×	338 0.6×	881 1.8×	248 0.8×	83 0.3×	96	2.6k
Yu Jiang China	27	1.0k 1.1×	667 1.2×	277 0.6×	419 1.4×	357 1.4×	119	2.5k
Laila Dahmoush United States	21	961 1.0×	643 1.1×	413 0.9×	257 0.8×	315 1.3×	52	2.8k
Gary A. Croghan United States	31	845 0.9×	1.3k 2.2×	509 1.1×	173 0.6×	347 1.4×	70	2.6k
Ornella Garrone Italy	27	2.0k 2.2×	1.2k 2.1×	629 1.3×	220 0.7×	176 0.7×	171	4.5k

Countries citing papers authored by Thomas Cerny

Since Specialization

Citations

This map shows the geographic impact of Thomas Cerny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Cerny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Cerny more than expected).

Fields of papers citing papers by Thomas Cerny

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Cerny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Cerny. The network helps show where Thomas Cerny may publish in the future.

Co-authorship network of co-authors of Thomas Cerny

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Cerny. A scholar is included among the top collaborators of Thomas Cerny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Cerny. Thomas Cerny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cerny, Thomas, et al.. (2017). Fear, Pain, Denial, and Spiritual Experiences in Dying Processes. American Journal of Hospice and Palliative Medicine®. 35(3). 478–491. 39 indexed citations

Fehr, Martin, Joachim Müller, Jürgen Fornaro, et al.. (2017). Early Postoperative FDG-PET-CT Imaging Results in a Relevant Upstaging in the pN2 Subgroup of Stage III Colorectal Cancer Patients. Clinical Colorectal Cancer. 16(4). 343–348. 3 indexed citations

Cerny, Thomas, Megan Schwarz, Urs Schwarz, et al.. (2017). The Range of Neurological Complications in Chikungunya Fever. Neurocritical Care. 27(3). 447–457. 74 indexed citations

Joos, Ladina, René Warschkow, André Dutly, et al.. (2016). Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study. Lung Cancer. 100. 38–44. 4 indexed citations

Warschkow, René, Ulrich Güller, Ignazio Tarantino, et al.. (2015). Improved Survival After Primary Tumor Surgery in Metastatic Breast Cancer. Annals of Surgery. 263(6). 1188–1198. 64 indexed citations

Joerger, Markus, Alwin D. R. Huitema, Henk Boot, et al.. (2015). Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy. Cancer Chemotherapy and Pharmacology. 75(4). 763–772. 47 indexed citations

Tarantino, Ignazio, René Warschkow, Mathias Worni, et al.. (2014). Prognostic Relevance of Palliative Primary Tumor Removal in 37,793 Metastatic Colorectal Cancer Patients. Annals of Surgery. 262(1). 112–120. 93 indexed citations

Joerger, Markus, Alwin D. R. Huitema, Dieter Koeberle, et al.. (2013). Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunction. Cancer Chemotherapy and Pharmacology. 73(1). 113–124. 7 indexed citations

Waeckerle‐Men, Ying, Edith Uetz‐von Allmen, M. Fopp, et al.. (2006). Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma. Cancer Immunology Immunotherapy. 55(12). 1524–1533. 95 indexed citations

10.

Cerny, Thomas. (2005). Anti-nicotine Vaccination: Where Are We?. Recent results in cancer research. 167–175. 23 indexed citations

11.

Früh, Martin, Thomas Ruhstaller, Jörg Neuweiler, & Thomas Cerny. (2004). Resection of Skin Metastases from Gastric Carcinoma with Long–Term Follow–Up: An Unusual Clinical Presentation. Oncology Research and Treatment. 28(1). 38–40. 13 indexed citations

12.

Gillessen, Silke, et al.. (2002). The Proteasome, a New Target for Cancer Therapy. Oncology Research and Treatment. 25(6). 534–539. 24 indexed citations

13.

Pfister, Marc, et al.. (2001). Elevated Carbohydrate Antigen 19-9 (CA 19-9) in Patients with Echinococcus Infection. Clinical Chemistry and Laboratory Medicine (CCLM). 39(6). 527–30. 10 indexed citations

14.

Friedl, Andrée, et al.. (2000). Pneumococcal Vaccine in Patients With Absent or Dysfunctional Spleen. Mayo Clinic Proceedings. 75(7). 749–753. 3 indexed citations

15.

Dannull, Jens, Thomas Cerny, Daniel Ackermann, & Marcus Groettrup. (2000). Current Status of Dendritic Cell-Based Tumor Vaccination. Oncology Research and Treatment. 23(6). 544–551. 3 indexed citations

16.

Betticher, Daniel, Jim Heighway, P S Hasleton, et al.. (1996). Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. British Journal of Cancer. 73(3). 294–300. 191 indexed citations

17.

Barth, Andreas S. & Thomas Cerny. (1994). [Current aspects in the treatment of malignant melanoma].. PubMed. 124(36). 1592–603. 1 indexed citations

18.

Lee, Siow Ming, Joseph A. Rafferty, Michael Bromley, et al.. (1992). Immunohistological examination of the inter- and intracellular distribution of O6-alkylguanine DNA-alkyltransferase in human liver and melanoma. British Journal of Cancer. 66(2). 355–360. 45 indexed citations

19.

Rentsch, Markus, et al.. (1989). [Radioimmunoscintigraphy with a 99mTc-labeled F(ab')2 fragment of a monoclonal antibody (HMW-MAA 225.28S) in 71 patients with malignant melanoma].. PubMed. 119(40). 1382–5. 3 indexed citations

20.

Ghosh, A K, Thomas Cerny, John Wagstaff, Nicholas Thatcher, & Michael G. Moore. (1989). Effect of in vivo administration of interferon gamma on expression of MHC products and tumour associated antigens in patients with metastatic melanoma. European Journal of Cancer and Clinical Oncology. 25(11). 1637–1643. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact